The allergy diagnostics market is estimated to reach USD 6,103.3 million in 2023, which will touch USD 12,814.2 million, with an 11.2% compound annual growth rate, by 2030.
The growth of this industry is because of the rising levels of environmental pollution, increasing investment to enhance allergy diagnostics by private & public administrations, and the occurrence of allergic disorders.
Furthermore, the inactive lifestyles, characterized by smoking, consumption of alcohol, and poor food habits; coupled with the high demand for in-vitro blood testing will further boost the industry expansion.
The consumables category, based on offering, is leading the industry in 2023, with a 45% share. This can be because consumables are an important component in detecting allergies.
North America is leading the industry in 2023, with a 55% share. This can be because of the strong healthcare system, swift technological developments in the medical sector, and advantageous reimbursement rules.
Additionally, the surging occurrence of allergies, coupled with the presence of inspiring procedures by associations to increase consciousness and make treatment and diagnosis available are also major contributors.
APAC will progress at the highest rate, of 11.5%, in the years to come. This can be primarily attributed to the requirement for less-invasive diagnostic technologies, speedily growing medical infrastructure, surging medical tourism activities, and unfulfilled clinical requirements.
With the rising levels of environmental pollution, the allergy diagnostics industry will continue to progress in the years to come.
